Table of contents

Papers

• “Summary measure” statistic for assessing the outcome of treatment trials in relapsing-remitting multiple sclerosis (1 June, 1998)

  Clarence Liu, Alain Li Wan Po, Lance D Blumhardt
• High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition (1 June, 1998)

  P M Rothwell, D Charlton
• Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis (1 June, 1998)

  S Edwards, M Zvartau, H Clarke, W Irving, L D Blumhardt
• Longitudinal SPECT study in Alzheimer’s disease: relation to apolipoprotein E polymorphism (1 June, 1998)

  M Lehtovirta, J Kuikka, S Helisalmi, P Hartikainen, A Mannermaa, M Ryynänen, P Sr Riekkinen, H Soininen
• Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial (1 June, 1998)

  Abdullah Z B Latif, David Signorini, Anna Gregor, Robin Grant, James W Ironside, Ian R Whittle
• Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases (1 June, 1998)

  Suthipun Jitpimolmard, Somsak Tiamkao, Malinee Laopaiboon
• Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington’s disease (1 June, 1998)

  I Vuillaume, P Vermersch, A Destée, H Petit, B Sablonnière
• Lightning stroke and neuropsychological impairment: cases and questions (1 June, 1998)

  Adriaan H van Zomeren, Henk-Jan ten Duis, Jan M Minderhoud, Mirjam Sipma
• Mechanisms of second and further strokes (1 June, 1998)

  Haruko Yamamoto, Julien Bogousslavsky
• Auditory evoked neuromagnetic response in cerebrovascular diseases: a preliminary study (1 June, 1998)

  Kazunori Toyoda, Setsuro Ibayashi, Tomoya Yamamoto, Yasuo Kuwabara, Masatoshi Fujishima